Everything NICE has said on cannabis-based medicinal products in an interactive flowchart.
Everything NICE has said on multiple sclerosis in an interactive flowchart
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
Patient access schemes and the NICE Patient Access Liaison Unit When assessing new drugs and treatments, NICE looks at the cost of the treatment and...
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.
A quick guide for home care managers on preventing deaths and illnesses associated with cold homes.
NICE quick guide - moving between hospital and home, including care homes
A quick guide for care home managers Jump to: Risk factors Recognising delirium Preventing delirium Sharing information Further information
A quick and easy-to-read guide to the standard of care you should expect from a home care provider.
Our European health technology assessment and regulatory concurrent advice service is designed to provide scientific advice from NICE within similar...
Scientific advice for developers of pharmaceuticals
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
The following NICE published diagnostics assessments have been transferred to the static list. Guidance is moved to the static list following...
NICE accreditation decisions
Formally endorses resources produced by external organisations that support the implementation of NICE guidance and the use of quality standards.
The NICE scientific advice team
Biographies of the NICE senior management team and minutes of their meetings
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5. It aims to improve clinical assessment and help healthcare professionals diagnose serious illness among young children who present with fever in primary and secondary care.
Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources. Previously known as the forward planner.
Jobs at NICE. Includes current vacancies, roles, location and salary information.
Everything NICE has said on assessing and initiating management of fever with no obvious cause in children under 5 in an interactive flowchart
Everything NICE has said on diagnosing, treating and managing urinary tract infections including lower (cystitis), upper (acute pyelonephritis) and recurrent UTIs in people with or without a catheter in an interactive flowchart
Everything NICE has said on the essential care that every woman and her baby should receive in the first 6–8 weeks after birth in an interactive flowchart
Everything NICE has said on managing bacterial meningitis and meningococcal septicaemia in children and young people in an interactive flowchart
Everything NICE has said on maternal and child nutrition in an interactive flowchart
Everything NICE has said on supporting the social and emotional wellbeing of children and young people in an interactive flowchart
Everything NICE has said on antenatal and postnatal mental health in an interactive flowchart
Tools and resources to help you implement guidance and quality standards at work.
Public Health Advisory Committees (PHACs) are the standing committees responsible for the development of NICE public health guidance. Each PHAC...
NICE diagnostics assessment recommendations are prepared by an independent advisory committee called the diagnostics advisory committee. Standing...
Provider grid Details of the Content Resources and services offered by appointed Providers under the NICE Electronic and Print Content Framework....
The Quality Standards Advisory Committees (QSAC) are independent committees that help to develop our quality standards. We have 3 committees who:...
Details, meeting dates and minutes of the independent technology appraisal committees
Information, meeting dates and minutes of the medical technologies advisory committee
NICE recommendations on the use of highly specialised technologies are made by an independent advisory committee called the Highly Specialised...
The information below provides a summary of known issues and upcoming changes related to NICE Evidence Services. This information will be updated...
We work with an independent Indicator Advisory Committee (IAC) to develop indicators suitable for potential inclusion in the Quality and Outcomes...
Everything NICE has said on diagnosing and managing bronchiolitis in children in an interactive flowchart
Advice on the use of DyeVert for reducing contrast media in coronary and peripheral angiography to aid local decision making
Advice on improving the quality of economic models
Find out more about the NICE Medical Technologies Advisory Committee members by reading their biographies. Professor Peter Groves Chair About
Scholarships are one year opportunities to improve quality of care and contribute to your professional development
Fellows are experience health and social care leaders who are our ambassadors at regional and national levels
A quick, easy way to access key information from NICE on social care topics.